Summary
Yann Abraham is a drug discovery leader with 12+ years translating complex single-cell and proteomics data into actionable insights across pharma and biotech, now heading Drug Discovery at DeepLife in Brussels. Trained as a biochemist with a PhD from Paris-Sud, he built quantitative biology capabilities at Novartis and advanced single-cell visualization and integration methods at Janssen, rising to Associate Scientific Director. He blends hands-on computational immunology—mass cytometry and scRNA-seq—with program-level decision making, enabling teams to move from high-dimensional data to target hypotheses. Colleagues rely on his mix of method development, LIMS/user-support experience, and pragmatic translational thinking to bridge discovery and project teams. An early adopter of medium-throughput, high-content assay analysis, he quietly leverages lab-savvy and coding fluency to accelerate target selection and de-risk projects.
12 years of coding experience
12 years of employment as a software developer
PhD Biochemistry, PhD Biochemistry at Paris-Sud University (Paris XI)
Licence Biology, Licence Biology at CY Cergy Paris Université
French, English